BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 19059502)

  • 1. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble, oligomeric, and ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility.
    Avramopoulou V; Mamalaki A; Tzartos SJ
    J Biol Chem; 2004 Sep; 279(37):38287-93. PubMed ID: 15226316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits in the yeast Pichia pastoris: glycosylation is not required for ligand binding.
    Stergiou C; Zisimopoulou P; Tzartos SJ
    J Biol Chem; 2011 Mar; 286(11):8884-92. PubMed ID: 21252231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular dichroism studies of extracellular domains of human nicotinic acetylcholine receptors provide an insight into their structure.
    Zouridakis M; Kostelidou K; Sotiriadis A; Stergiou C; Eliopoulos E; Poulas K; Tzartos SJ
    Int J Biol Macromol; 2007 Oct; 41(4):423-9. PubMed ID: 17659334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.
    Lyukmanova EN; Shulepko MA; Buldakova SL; Kasheverov IE; Shenkarev ZO; Reshetnikov RV; Filkin SY; Kudryavtsev DS; Ojomoko LO; Kryukova EV; Dolgikh DA; Kirpichnikov MP; Bregestovski PD; Tsetlin VI
    J Biol Chem; 2013 May; 288(22):15888-99. PubMed ID: 23585571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and spectroscopic analysis of soluble nicotinic acetylcholine receptor fragments derived from the extracellular domain of the alpha-subunit.
    Grant MA; Gentile LN; Shi QL; Pellegrini M; Hawrot E
    Biochemistry; 1999 Aug; 38(33):10730-42. PubMed ID: 10451368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human AChR extracellular domain mutants with improved characteristics.
    Lazaridis K; Zisimopoulou P; Giastas P; Bitzopoulou K; Evangelakou P; Sideri A; Tzartos SJ
    Int J Biol Macromol; 2014 Feb; 63():210-7. PubMed ID: 24246999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop.
    Bitzopoulou K; Kostelidou K; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2008 Sep; 1784(9):1226-33. PubMed ID: 18502212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
    Marinou M; Tzartos SJ
    Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model of the extracellular domain of the human alpha7 nAChR based on the crystal structure of the mouse alpha1 nAChR extracellular domain.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    J Mol Graph Model; 2008 Jun; 26(8):1333-7. PubMed ID: 18329305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of alpha-conotoxin ImII and its analogs with nicotinic receptors and acetylcholine-binding proteins: additional binding sites on Torpedo receptor.
    Kasheverov IE; Zhmak MN; Fish A; Rucktooa P; Khruschov AY; Osipov AV; Ziganshin RH; D'hoedt D; Bertrand D; Sixma TK; Smit AB; Tsetlin VI
    J Neurochem; 2009 Nov; 111(4):934-44. PubMed ID: 19712060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.
    Spurny R; Debaveye S; Farinha A; Veys K; Vos AM; Gossas T; Atack J; Bertrand S; Bertrand D; Danielson UH; Tresadern G; Ulens C
    Proc Natl Acad Sci U S A; 2015 May; 112(19):E2543-52. PubMed ID: 25918415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera.
    Huang S; Li SX; Bren N; Cheng K; Gomoto R; Chen L; Sine SM
    Biochem J; 2013 Sep; 454(2):303-310. PubMed ID: 23800261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for soluble overexpression of the alpha7 nicotinic acetylcholine receptor extracellular domain.
    Fischer M; Corringer PJ; Schott K; Bacher A; Changeux JP
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3567-70. PubMed ID: 11248118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of Dalpha6 and Dalpha7 nicotinic acetylcholine receptor subunits from Drosophila: formation of a high-affinity alpha-bungarotoxin binding site revealed by expression of subunit chimeras.
    Lansdell SJ; Millar NS
    J Neurochem; 2004 Jul; 90(2):479-89. PubMed ID: 15228604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.